ZA882189B - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
ZA882189B
ZA882189B ZA882189A ZA882189A ZA882189B ZA 882189 B ZA882189 B ZA 882189B ZA 882189 A ZA882189 A ZA 882189A ZA 882189 A ZA882189 A ZA 882189A ZA 882189 B ZA882189 B ZA 882189B
Authority
ZA
South Africa
Prior art keywords
preparation
quickly
aqueous
iodine
application
Prior art date
Application number
ZA882189A
Other languages
English (en)
Inventor
Helmut Rackur Dr.
Erwig Pinter Dr.
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of ZA882189B publication Critical patent/ZA882189B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA882189A 1987-04-02 1988-03-28 Pharmaceutical preparation ZA882189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873711083 DE3711083A1 (de) 1987-04-02 1987-04-02 Pharmazeutisches praeparat

Publications (1)

Publication Number Publication Date
ZA882189B true ZA882189B (en) 1988-09-16

Family

ID=6324697

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882189A ZA882189B (en) 1987-04-02 1988-03-28 Pharmaceutical preparation

Country Status (11)

Country Link
EP (1) EP0284999B1 (de)
JP (1) JP2786634B2 (de)
AT (1) ATE70188T1 (de)
AU (1) AU610147B2 (de)
CA (1) CA1320444C (de)
DE (2) DE3711083A1 (de)
DK (1) DK166761B1 (de)
ES (1) ES2039266T3 (de)
GR (1) GR3003353T3 (de)
NO (1) NO175187C (de)
ZA (1) ZA882189B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232692A (en) * 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
JP2661783B2 (ja) * 1990-09-21 1997-10-08 明治製菓株式会社 擦式手指消毒用医薬品組成物
GB2378136A (en) * 2001-08-01 2003-02-05 Thomas David White Disinfectant formulation and method for determining sporicidal activity
US7704935B1 (en) * 2009-01-06 2010-04-27 Becton, Dickinson And Company Chlorhexidine acetate antiseptic cleaning agent
WO2016209966A1 (en) 2015-06-22 2016-12-29 Infection Containment Company, LLC Topical antiseptic system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB414098A (de) * 1900-01-01
DE389778C (de) * 1920-10-12 1924-02-07 Chemia Ungarische Chemische In Verfahren zur Darstellung fester Jodloesungen
US4012504A (en) * 1972-05-12 1977-03-15 Velvet Chemical Co. Iodine mineral oil solution for preventing bovine mastitis
CH612984A5 (de) * 1974-12-02 1979-08-31 Ciba Geigy Ag
US4301145A (en) * 1980-07-28 1981-11-17 Cestari Joseph E Antiseptic skin cream
DE3313655C2 (de) * 1983-03-02 1995-03-23 Euro Celtique Sa Pharmazeutisches Jodophor-Präparat
IL77224A (en) * 1984-12-12 1989-09-10 Euro Celtique Sa Antibacterial cream

Also Published As

Publication number Publication date
JPS63264528A (ja) 1988-11-01
GR3003353T3 (en) 1993-02-17
DK179488A (da) 1988-10-03
DK179488D0 (da) 1988-03-30
DE3711083A1 (de) 1988-10-13
CA1320444C (en) 1993-07-20
NO175187C (no) 1994-09-14
NO881424L (no) 1988-10-03
DE3866747D1 (de) 1992-01-23
EP0284999B1 (de) 1991-12-11
JP2786634B2 (ja) 1998-08-13
DK166761B1 (da) 1993-07-12
EP0284999A1 (de) 1988-10-05
ATE70188T1 (de) 1991-12-15
AU610147B2 (en) 1991-05-16
NO881424D0 (no) 1988-03-30
AU1417388A (en) 1988-10-06
ES2039266T3 (es) 1995-04-01
NO175187B (de) 1994-06-06

Similar Documents

Publication Publication Date Title
ES8101855A1 (es) Un procedimiento para la preparacion de una composicion co- loidal lipidica de dihexanoil-lecitina
MX173607B (es) Antitranspirante cristalino y metodo para su preparacion
EP0305380A4 (de) Neue topische metronidazol-formulierungen.
ZA882189B (en) Pharmaceutical preparation
KR930000096A (ko) 제제
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
ES2069212T3 (es) Procedimiento para la preparacion de una proteina transparente del suero de la leche ajustada y un producto de proteina del suero de la leche ajustada.
ES495831A0 (es) Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
FR2336121A1 (fr) Nouveau procede de preparation de produits cosmetiques d'origine foetale, et produits obtenus
US3152951A (en) Germicidal composition of iodine and liquid lanolin
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
NO912890L (no) Preparat inneholdende salicylsyre for behandling av hudsykdommer med avskalling.
IT1243414B (it) Preparato balsamico per uso topico
RU94023800A (ru) Диарин для лечения и профилактики желудочно-кишечных болезней молодняка животных
JPS5517327A (en) Liquid drug for external use, and its preparation
Yuge et al. Results on the Treatment of the Fractures of the Lower Extremity
HILL et al. Amphiphile Nature of κ-Casein as the Basis for its Micelle Stabilizing Property
KR830000507A (ko) 농업 및 원예용 살균조성물
Reed Variational treatment of the linear potential
Miyake Studies on B1-Effect of Thiamine Tetrahydrofurfuryldisulfide (TTFD) Part 3. The reduction TTFD to vitamin B 1 by means of the liver homogenate solution
JPS5636410A (en) Ointment for treating athlete's foot
JPS53148526A (en) Aseptic and mildewcidal agent for food
CHIKAZAWA et al. Therapeutic Effect of Processed Aconiti Tuber on Rheumatoid Arthritis and Its Pharmacological Analysis
DE JONG et al. Haemoglobin Leiden: Deletion of β6 or 7 Glutamic Acid
ES2100856T3 (es) Pomada dermoprotectora.